- Learn More
We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Nick Groombridge to Speak at ACI’s Biosimilars & Innovator Biologics Summit
- June 22, 2021
On June 23, litigation partner Nick Groombridge will speak on a panel, “The Future of Patent Thickets: Balancing Innovation and Competition in the Biologic Ecosystem,” as part of the American Conference Institute’s 12th Biosimilars & Innovator Biologics Summit. Nick and his co-panelists will discuss the intellectual property landscape for biologic drugs and whether developing a so-called “patent thicket” can be an antitrust violation. The two-day conference promotes in-depth discussions on the legal, regulatory and commercial strategies for the innovator and biosimilars marketplace.
The panel will be held on June 23 at 1:45 p.m. ET.